First Cat-Specific Blood Pressure Drug Approved — and the FDA File Shows Why Catching It Late Costs Vision
On April 29, 2026 the FDA approved AMODIP (amlodipine besylate chewable tablets, Ceva) — the first cat-specific drug for systemic hypertension in cats. In the field study systolic pressure fell 28.2 mmHg on average by Day 28. But the same FDA file notes that cats whose vision was already severely lost at treatment start were less likely to regain it even after the retina reattached. Feline hypertension travels with kidney disease and is invisible at home. What to do now.

What Was Approved

midArticleCta.byCategory.news.title
midArticleCta.byCategory.news.description
Понад 380 000 власників котів у 50 країнах довіряють CatsMe
Feline Hypertension Travels With Kidney Disease — and Shows You Nothing at Home
The Real Story Is One Sentence in the FDA File
Cats that had severe fundic lesions and severely decreased or absent vision at the start of treatment were less likely to regain visual function, despite retinal reattachment and improvement in retinal hemorrhages.
What To Do Now: Start by Asking for the Measurement
Turn Invisible Change Into a Record — CatsMe
Чи зможете ви відповісти: «Коли це почалося?»
Коли ветеринар запитає, не залишайтесь без відповіді. CatsMe автоматично веде щоденний журнал здоров'я, яким можна поділитися одним дотиком.
FAQ

Будьте готові діяти, щойно відчуєте неладне
Достатньо одного фото: ШІ зчитує біль і стан здоров'я з виразу морди кота. Перевірте в момент тривоги й поділіться записами з ветеринаром.